Vessel Wall Changes on Serial High-Resolution MRI and the Use of Cilostazol in Patients With Adult-Onset Moyamoya Disease

CONCLUSIONS: Adult-onset MMD induces progressive shrinkage of large intracranial arteries, which cilostazol treatment may prevent. Further randomized clinical trials are warranted.TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02074111.PMID:36367058 | DOI:10.3988/jcn.2022.18.6.610
Source: Journal of Clinical Neurology - Category: Neurology Authors: Source Type: research